4//SEC Filing
EYEGATE PHARMACEUTICALS INC 4
Accession 0001144204-16-096682
$KPRXCIK 0001372514operating
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 5:32 PM ET
Size
5.8 KB
Accession
0001144204-16-096682
Insider Transaction Report
Form 4
Brenneman Ryan Randall
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-04-25+41,732→ 41,732 totalExercise: $3.23Exp: 2026-04-25→ Common Stock (41,732 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on April 25, 2017, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the Reporting Person's continued employment through each such vesting date.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeoperating
Related Parties
1- filerCIK 0001372514
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 5:32 PM ET
- Size
- 5.8 KB